Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Cell Rep
2013 Aug 29;44:803-16. doi: 10.1016/j.celrep.2013.07.031.
Show Gene links
Show Anatomy links
SCF-mediated Cdh1 degradation defines a negative feedback system that coordinates cell-cycle progression.
Fukushima H
,
Ogura K
,
Wan L
,
Lu Y
,
Li V
,
Gao D
,
Liu P
,
Lau AW
,
Wu T
,
Kirschner MW
,
Inuzuka H
,
Wei W
.
???displayArticle.abstract???
Proper cell-cycle transitions are driven by waves of ubiquitin-dependent degradation of key regulators by the anaphase-promoting complex (APC) and Skp1-Cullin1-F-box (SCF) E3 ubiquitin ligase complexes. But precisely how APC and SCF activities are coordinated to regulate cell-cycle progression remains largely unclear. We previously showed that APC/Cdh1 earmarks the SCF component Skp2 for degradation. Here, we continue to report that SCF(β-TRCP) reciprocally controls APC/Cdh1 activity by governing Cdh1 ubiquitination and subsequent degradation. Furthermore, we define both cyclin A and Plk1, two well-known Cdh1 substrates, as upstream modifying enzymes that promote Cdh1 phosphorylation to trigger Cdh1 ubiquitination and subsequent degradation by SCF(β-TRCP). Thus, our work reveals a negative repression mechanism for SCF to control APC, thereby illustrating an elegant dual repression system between these two E3 ligase complexes to create the ordered cascade of APC and SCF activities governing timely cell-cycle transitions.
Bashir,
Control of the SCF(Skp2-Cks1) ubiquitin ligase by the APC/C(Cdh1) ubiquitin ligase.
2004, Pubmed
Bashir,
Control of the SCF(Skp2-Cks1) ubiquitin ligase by the APC/C(Cdh1) ubiquitin ligase.
2004,
Pubmed
Benmaamar,
Involvement of the SCF complex in the control of Cdh1 degradation in S-phase.
2005,
Pubmed
Boehm,
Transformation of human and murine fibroblasts without viral oncoproteins.
2005,
Pubmed
Brooks,
p53 regulation by ubiquitin.
2011,
Pubmed
Cardozo,
The SCF ubiquitin ligase: insights into a molecular machine.
2004,
Pubmed
Conradie,
Restriction point control of the mammalian cell cycle via the cyclin E/Cdk2:p27 complex.
2010,
Pubmed
Dephoure,
A quantitative atlas of mitotic phosphorylation.
2008,
Pubmed
Elia,
Proteomic screen finds pSer/pThr-binding domain localizing Plk1 to mitotic substrates.
2003,
Pubmed
Elia,
The molecular basis for phosphodependent substrate targeting and regulation of Plks by the Polo-box domain.
2003,
Pubmed
,
Xenbase
Fasano,
shRNA knockdown of Bmi-1 reveals a critical role for p21-Rb pathway in NSC self-renewal during development.
2007,
Pubmed
Fuchs,
The many faces of beta-TrCP E3 ubiquitin ligases: reflections in the magic mirror of cancer.
2004,
Pubmed
Gao,
Cdh1 regulates cell cycle through modulating the claspin/Chk1 and the Rb/E2F1 pathways.
2009,
Pubmed
Gao,
mTOR drives its own activation via SCF(βTrCP)-dependent degradation of the mTOR inhibitor DEPTOR.
2011,
Pubmed
Gao,
Rictor forms a complex with Cullin-1 to promote SGK1 ubiquitination and destruction.
2010,
Pubmed
Gao,
Phosphorylation by Akt1 promotes cytoplasmic localization of Skp2 and impairs APCCdh1-mediated Skp2 destruction.
2009,
Pubmed
Harper,
The anaphase-promoting complex: it's not just for mitosis any more.
2002,
Pubmed
Hong,
Suppression of induced pluripotent stem cell generation by the p53-p21 pathway.
2009,
Pubmed
Hsu,
E2F-dependent accumulation of hEmi1 regulates S phase entry by inhibiting APC(Cdh1).
2002,
Pubmed
,
Xenbase
Inuzuka,
Phosphorylation by casein kinase I promotes the turnover of the Mdm2 oncoprotein via the SCF(beta-TRCP) ubiquitin ligase.
2010,
Pubmed
Janzen,
Stem-cell ageing modified by the cyclin-dependent kinase inhibitor p16INK4a.
2006,
Pubmed
Jin,
SCFbeta-TRCP links Chk1 signaling to degradation of the Cdc25A protein phosphatase.
2003,
Pubmed
Keck,
Cyclin E overexpression impairs progression through mitosis by inhibiting APC(Cdh1).
2007,
Pubmed
Kroll,
Geminin, a neuralizing molecule that demarcates the future neural plate at the onset of gastrulation.
1998,
Pubmed
,
Xenbase
Lassot,
ATF4 degradation relies on a phosphorylation-dependent interaction with the SCF(betaTrCP) ubiquitin ligase.
2001,
Pubmed
Lau,
Regulation of APC(Cdh1) E3 ligase activity by the Fbw7/cyclin E signaling axis contributes to the tumor suppressor function of Fbw7.
2013,
Pubmed
Listovsky,
Mammalian Cdh1/Fzr mediates its own degradation.
2004,
Pubmed
,
Xenbase
Liu,
Proteolysis of CDH1 enhances susceptibility to UV radiation-induced apoptosis.
2008,
Pubmed
Lu,
Periodic cyclin-Cdk activity entrains an autonomous Cdc14 release oscillator.
2010,
Pubmed
Lu,
Ubiquitylation and proteasomal degradation of the p21(Cip1), p27(Kip1) and p57(Kip2) CDK inhibitors.
2010,
Pubmed
Lukas,
Accumulation of cyclin B1 requires E2F and cyclin-A-dependent rearrangement of the anaphase-promoting complex.
1999,
Pubmed
Miller,
Emi1 stably binds and inhibits the anaphase-promoting complex/cyclosome as a pseudosubstrate inhibitor.
2006,
Pubmed
Nakajima,
Identification of a consensus motif for Plk (Polo-like kinase) phosphorylation reveals Myt1 as a Plk1 substrate.
2003,
Pubmed
,
Xenbase
Nakayama,
Regulation of the cell cycle at the G1-S transition by proteolysis of cyclin E and p27Kip1.
2001,
Pubmed
Nakayama,
Regulation of the cell cycle by SCF-type ubiquitin ligases.
2005,
Pubmed
Oshimori,
The Plk1 target Kizuna stabilizes mitotic centrosomes to ensure spindle bipolarity.
2006,
Pubmed
Peng,
Xenopus laevis: Practical uses in cell and molecular biology. Solutions and protocols.
1991,
Pubmed
,
Xenbase
Peters,
The anaphase-promoting complex: proteolysis in mitosis and beyond.
2002,
Pubmed
Peters,
The anaphase promoting complex/cyclosome: a machine designed to destroy.
2006,
Pubmed
Petroski,
Function and regulation of cullin-RING ubiquitin ligases.
2005,
Pubmed
Robbins,
Requirements and reasons for effective inhibition of the anaphase promoting complex activator CDH1.
2010,
Pubmed
Seo,
Multiple isoforms of beta-TrCP display differential activities in the regulation of Wnt signaling.
2009,
Pubmed
,
Xenbase
Sharma,
Oncogene addiction: setting the stage for molecularly targeted cancer therapy.
2007,
Pubmed
Sorensen,
Nonperiodic activity of the human anaphase-promoting complex-Cdh1 ubiquitin ligase results in continuous DNA synthesis uncoupled from mitosis.
2000,
Pubmed
Sørensen,
A conserved cyclin-binding domain determines functional interplay between anaphase-promoting complex-Cdh1 and cyclin A-Cdk2 during cell cycle progression.
2001,
Pubmed
Spiegelman,
Induction of beta-transducin repeat-containing protein by JNK signaling and its role in the activation of NF-kappaB.
2001,
Pubmed
Spiegelman,
Inhibition of HOS expression and activities by Wnt pathway.
2002,
Pubmed
Steegmaier,
BI 2536, a potent and selective inhibitor of polo-like kinase 1, inhibits tumor growth in vivo.
2007,
Pubmed
Wan,
Cdh1 regulates osteoblast function through an APC/C-independent modulation of Smurf1.
2011,
Pubmed
Wang,
Evidence for the direct involvement of {beta}TrCP in Gli3 protein processing.
2006,
Pubmed
Wäsch,
APC-dependent proteolysis of the mitotic cyclin Clb2 is essential for mitotic exit.
2002,
Pubmed
Wei,
Degradation of the SCF component Skp2 in cell-cycle phase G1 by the anaphase-promoting complex.
2004,
Pubmed
,
Xenbase
